- Home
- Internal Medicine
- REGN9933 (A2 Domain) – A Novel Anticoagulant for Venous Thromboembolism Prevention
3w3 min read
Medical Article
Introduction: Postoperative venous thromboembolism (VTE) remains a common and serious complication following major orthopedic procedures such as total knee arthroplasty (TKA). While conventional anticoagulants reduce VTE risk, their bleeding liability limits use in certain patient populations, especially those at increased hemorrhagic risk (1). Inh

REGN9933 (A2 Domain) – A Novel Anticoagulant for Venous Thromboembolism Prevention
2 Reached
Similar Content

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
